NMR vs CRCL
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 22, 2026
NMR
CRCL
Investment Advisor Scores
CRCL
AI Analyst Insights
Detailed Metrics Comparison
| Metric | NMR | CRCL | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 15.3846 | 65.3595 | NMR |
| PEG Ratio | 0.8146 | 6.8553 | NMR |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 31.2% | 6.6% | NMR |
| Earnings Growth | 42.0% | -80.9% | NMR |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 58.9/100 | 39.9/100 | NMR |
| Profit Margin | 17.3% | 15.5% | NMR |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | EXTENDED | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
NMR
MarkupPrice above SMA50, rising 50-day trend (6.7% over 20 days), RSI 53
CRCL
NeutralMixed signals - no dominant trend phase, RSI 69
Fundamentals Snapshot
| Metric | NMR | CRCL |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 13.0 | 63.6 |
| Trailing P/E | 11.4 | 15.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.1% |
| Gross Margin | 0.8% | 0.2% |
| Operating Margin | 0.3% | 0.0% |
| EPS | 0.83 | 5.31 |
| Dividend Yield | 0.03% | — |